Gossamer Bio (GOSS) EBIT Margin: 2022-2025
Historic EBIT Margin for Gossamer Bio (GOSS) over the last 4 years, with Sep 2025 value amounting to -369.44%.
- Gossamer Bio's EBIT Margin fell 1165.00% to -369.44% in Q3 2025 from the same period last year, while for Sep 2025 it was -802.08%, marking a year-over-year decrease of 72849.00%. This contributed to the annual value of -66.06% for FY2024, which is 142613.00% down from last year.
- As of Q3 2025, Gossamer Bio's EBIT Margin stood at -369.44%, which was down 9.49% from -337.41% recorded in Q2 2025.
- Gossamer Bio's 5-year EBIT Margin high stood at 1,612.12% for Q3 2022, and its period low was -372.23% during Q1 2025.
- Over the past 3 years, Gossamer Bio's median EBIT Margin value was 247.08% (recorded in 2024), while the average stood at 513.67%.
- Data for Gossamer Bio's EBIT Margin shows a maximum YoY crashed of 171,320bps (in 2025) over the last 5 years.
- Quarterly analysis of 4 years shows Gossamer Bio's EBIT Margin stood at 1,572.37% in 2022, then plummeted by 5,873bps to 1,513.65% in 2023, then slumped by 126,657bps to 247.08% in 2024, then slumped by 1,165bps to -369.44% in 2025.
- Its last three reported values are -369.44% in Q3 2025, -337.41% for Q2 2025, and -372.23% during Q1 2025.